Health Technology · Pharmaceuticals: Major · NSE: BLUEJET · data 2026-10-09
Blue Jet Healthcare Limited
Health check: Average (6/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹514.6
Market cap
₹9,826 cr
P/E
38
P/B
—
ROE
19.9%
ROCE
21.1%
Debt / equity
0.03
Dividend yield
0.23%
1-year return
-23.2%
52-week high
₹688.5
52-week low
₹325
Operating margin
27.8%
Growth
| Revenue (last 12 months) | ₹886 cr |
| Net profit (last 12 months) | ₹235 cr |
| Sales growth, 3 years (yearly) | 9.5% |
| Profit growth, 3 years (yearly) | 15.7% |
Similar companies
Viyash Scientific Limited (VIYASH) · Strides Pharma Science Ltd (STAR) · Procter & Gamble Health Ltd. (PGHL) · Sanofi Consumer Healthcare India Limited (SANOFICONR) · Suven Life Sciences Limited (SUVEN)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open BLUEJET in NSE Scanner →